AGA Medical Holdings has received EUR2.1m in damages from Dusseldorf Regional Court in relation to a patent infringement case against Jena, Germany-based Occlutech.

AGA Medical had sued Occlutech for patent infringement of the German part of one of its European patents, granted in October 2005, for intravascular occlusion devices and the method of manufacturing such devices.

The EUR2.1m awarded to AGA Medical was the amount the company sought. Although subject to appeal, AGA Medical is entitled to immediately enforce the decision.

John Barr, president and CEO of AGA Medical, said: “AGA Medical has prevailed against Occlutech in two different branches of the German courts, won cases with respect to both patent validity and infringement, and now has been awarded significant damages by the Dusseldorf court. Each positive ruling reinforces the strength of our patent portfolio and Occlutech’s infringement of our intellectual property.”

AGA Medical is a developer of interventional devices for the minimally invasive treatment of structural heart defects and vascular abnormalities.